openPR Logo
Press release

Anti-Hypertensive Drugs Market Size, Trends, Latest Insights, Analysis and Forecast 2023-2030

05-02-2024 03:43 PM CET | Health & Medicine

Press release from: Orion Market Research

Anti-Hypertensive Drugs Market Size, Trends, Latest Insights,

The global anti-hypertension drugs market is estimated to grow at a CAGR of over 4% during the forecast period. Hypertension is a common condition among patients with diabetes. Hence, the adoption of anti-hypertensive is high among the diabetic population for the treatment of hypertension. Hence, the increased diabetic population coupled with the adoption of anti-hypertensive drugs is anticipated to drive the anti-hypertensive drug market industry significantly. Additionally, Angiotensin-converting enzyme (ACE) inhibitors manufactured by companies such as Novartis AG and Pfizer Inc. are the most used anti-hypertensive drugs by diabetic patients.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market

Furthermore, hypertension is a major risk factor for patients suffering from conditions such as atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications. ASCVD is considered to be a leading cause of morbidity and mortality in patients with diabetes. In recent years, numerous studies have shown that anti-hypertensive drug therapy can aid in significantly reducing ASCVD events. Along with ASCVD, anti-hypertensive drugs can aid in conditions such as heart failure, and microvascular complications in diabetic patients. Hence, the positive effects of anti-hypertensive drugs on ASCVD and other conditions are anticipated to drive the anti-hypertensive drugs market growth considerably during the forecast period.

Additionally, anti-hypertensive drug-based treatment can be given to the patient either as monotherapy or in suitable combinations. In addition to this, anti-hypertensive drugs also shows good outcomes when used for non-pharmacological treatment such as low salt diet, weight loss, exercise, in diabetic patients which impact the anti-hypertensive drug market. Moreover, various government organizations across the globe are involved in the study of hypertension in diabetic patients that have also suggested the use of anti-hypertensive drugs in their guidelines, which in turn, is expected to expand the anti-hypertensive drug market size.

For instance, in the guidelines from European Society of Hypertension (ESH) and European Society of Cardiology, the use of drugs such as thiazide diuretics, ?-blockers, calcium channel blockers (CCBs), ACEis and angiotensin II receptor blockers (ARBs) are recommended for the initiation and maintenance of hypertension in diabetic patients. The drugs recommended in guidelines are anti-hypertensive drugs that are preferred to be used mostly in diabetic patients. Therefore, the guidelines from ESH and European Society of Cardiology, regarding the use of anti-hypertensive drugs are expected to drive the anti-hypertensive drugs market growth significantly during the forecasted period.

Anti-Hypertensive Drugs Market- Segmentation

By Drug Class

• Thiazide Diuretics
• Calcium Channel Blockers
• ACE Inhibitors
• Angiotensin II Receptor Antagonists (ARBS)
• Beta-Blockers
• Others

A full report of Global Anti-Hypertensive Drugs Market is available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market

Global Anti-Hypertensive Drugs Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co., Ltd.
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck KGaA
• Noden Pharma DAC
• Novartis International AG
• Pfizer Inc.
• Ranbaxy Laboratories Ltd.
• Renata Ltd.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Hypertensive Drugs Market Size, Trends, Latest Insights, Analysis and Forecast 2023-2030 here

News-ID: 3483083 • Views:

More Releases from Orion Market Research

US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecas …
The US geriatric medicine market is projected to grow at a CAGR of 4.6% during the forecast period. The US has high per capita income; access to advanced healthcare, a large elderly population, and a high prevalence of chronic diseases are some of the major factors driving the geriatric medicine market in the country. Moreover, a significant presence of key market players, such as Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global urometer market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period. The increasing cases of prostate cancer are expected to propel the growth of the global urometer market. Other than skin cancer, prostate cancer is the most common cancer in the US. According to the American Cancer Society (ACS), as of March 2022, around 268,490 new cases of prostate cancer and around
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global urethral dilators market is anticipated to grow at a considerable CAGR of 4.9% during the forecast. The growing incidence of Healthcare-Acquired Infections (HAI) is Boosting the Global Urethral Dilators Market. These are infections that patients get while receiving treatment for medical or surgical conditions. These infections can be occurred in hospitals, surgical centers, ambulatory clinics, and long-term care facilities such as nursing homes and rehabilitation facilities. To
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
The global transvaginal endoscopy market is anticipated to grow at a significant CAGR of 7.3% during the forecast period. Some of the prominent factors driving the market growth during the forecast period include the rising incidence of infertility among the female rising incidence of infertility globally, coupled with the increasing use of minimally invasive surgery. The MIS procedures involves minminal use of surgical incisions, and with the advent of laproscopic

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug